Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Bronchopulmonary dysplasia (BPD) is potentially one of the most devastating conditions in premature infants with longstanding consequences involving multiple organ systems including adverse effects on pulmonary function and neurodevelopmental outcome. Here we review recent studies in the field to summarize the progress made in understanding in the pathophysiology, prognosis, prevention, and treatment of BPD in the last decade. The work reviewed includes the progress in understanding its pathobiology, genomic studies, ventilatory strategies, outcomes, and therapeutic interventions. We expect that this review will help guide clinicians to treat premature infants at risk for BPD better and lead researchers to initiate further studies in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Northway, W. H., Rosan, R. C., & Porter, D. Y. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760701 · Cited by 3,013 · cited 1×
“In 1967, Northway first described Bronchopulmonary Dysplasia (BPD) as a lung disease in premature infants, who required prolonged mechanical ventilation [1].”
BackgroundAbman, S. H., Hansmann, G., Archer, S. L., Ivy, D. D., Adatia, I., Chung, W. K., Hanna, B. D., Rosenzweig, E. B., Raj, J. U., Cornfield, D., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000329 · Cited by 1,164
Chronic Lung Disease after Premature Birth
Baraldi, E., & Filippone, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067279 · Cited by 1,070
Target Ranges of Oxygen Saturation in Extremely Preterm Infants
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911781 · Cited by 961
Rojas-Reyes, M. X., Morley, C. J., & Soll, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000510.pub2 · Cited by 652
Stevens, T. P., Blennow, M., Myers, E. H., & Soll, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003063.pub3 · Cited by 597
Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
Tyson, J. E., Wright, L. L., Oh, W., Kennedy, K. A., Mele, L., Ehrenkranz, R. A., Stoll, B. J., Lemons, J. A., Stevenson, D. K., Bauer, C. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402505 · Cited by 561
Fawke, J., Lum, S., Kirkby, J., Hennessy, E., Marlow, N., Rowell, V., Thomas, S., & Stocks, J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1806oc · Cited by 535
Oxygen-Saturation Targets and Outcomes in Extremely Preterm Infants
Askie, L. M., Henderson-Smart, D. J., Irwig, L., & Simpson, J. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023080 · Cited by 524 · cited 1×
“Another study implied that targeting the functional oxygen saturation in 95–98% range rather than in 91–94% range improved growth and neurodevelopment in preterm infants, but this was at the expense of an increased risk of BPD and a higher mortality from pulmonary causes [47].”
BackgroundMesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical Trial
Chang, Y. S., Ahn, S. Y., Yoo, H. S., Sung, S. I., Choi, S. J., Oh, W. I., & Park, W. S. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.12.011 · Cited by 455 · cited 1×
“the control group without any adverse outcomes [76].”
Background
Metadata
- Authors
- Hwang, J. S., & Rehan, V. K.
- Venue
- Lung
- Published
- 2018-01-27
- Volume
- 196
- Issue
- 2
- Pages
- 129-138
- ISSN
- 0341-2040 (ISSN-L)
- 1432-1750
- OpenAlex
- W2792811894
- Cited by
- 215
- References
- 71
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment. https://app.cochat.ai/papers/10.1007/s00408-018-0084-z
- The paper
- Hwang, J. S., & Rehan, V. K. (2018). Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment. Lung. https://doi.org/10.1007/s00408-018-0084-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.